Li Ping Hong
Direktor/Vorstandsmitglied bei HONZ PHARMACEUTICAL CO., LTD.
Aktive Positionen von Li Ping Hong
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HONZ PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 20.12.2007 | - |
| Corporate Officer/Principal | 20.12.2007 | - | |
| Hainan Honz Pharmaceutical Sales Co. Ltd. | Direktor/Vorstandsmitglied | - | - |
| Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd. | Direktor/Vorstandsmitglied | - | - |
Guangdong Yuanning Pharmaceutical Co. Ltd.
 Guangdong Yuanning Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Honz Pharmaceutical Co., Ltd., Guangdong Yuanning Pharmaceutical Co. Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. Guangdong Yuanning Pharmaceutical Co. was acquired by Honz Pharmaceutical Co., Ltd. from Guangdong Yingkang Pharmaceutical Co. Ltd. on August 18, 2014 for $6.25 million. | Direktor/Vorstandsmitglied | - | - |
Guangdong Kangzhi Hospital Management Co., Ltd.
 Guangdong Kangzhi Hospital Management Co., Ltd. Packaged SoftwareTechnology Services Part of Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/, Guangdong Kangzhi Hospital Management Co., Ltd. develops computer software. The company is based in Guangzhou, China. The Chinese company was founded in 2018. Li Ping Hong has been the CEO of the company since 2018. Guangdong Kangzhi Hospital Management Co. was acquired by Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/ from Tianjin Binhai Yuanxian Management Consulting Center LP on July 13, 2022 for $74.69 million. | Direktor/Vorstandsmitglied | 20.06.2018 | - |
| Vorstandsvorsitzender | 20.06.2018 | - |
Karriereverlauf von Li Ping Hong
Ausbildung von Li Ping Hong
| Guangdong Pharmaceutical University | Undergraduate Degree |
Statistik
International
| China | 7 |
Operativ
| Director/Board Member | 5 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HONZ PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Hainan Honz Pharmaceutical Sales Co. Ltd. | |
| Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd. | |
Guangdong Yuanning Pharmaceutical Co. Ltd.
Guangdong Yuanning Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Honz Pharmaceutical Co., Ltd., Guangdong Yuanning Pharmaceutical Co. Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. Guangdong Yuanning Pharmaceutical Co. was acquired by Honz Pharmaceutical Co., Ltd. from Guangdong Yingkang Pharmaceutical Co. Ltd. on August 18, 2014 for $6.25 million. | Health Technology |
Guangdong Kangzhi Hospital Management Co., Ltd.
Guangdong Kangzhi Hospital Management Co., Ltd. Packaged SoftwareTechnology Services Part of Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/, Guangdong Kangzhi Hospital Management Co., Ltd. develops computer software. The company is based in Guangzhou, China. The Chinese company was founded in 2018. Li Ping Hong has been the CEO of the company since 2018. Guangdong Kangzhi Hospital Management Co. was acquired by Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/ from Tianjin Binhai Yuanxian Management Consulting Center LP on July 13, 2022 for $74.69 million. | Technology Services |
- Börse
- Insiders
- Li Ping Hong
- Erfahrung
